Search research articles
Contact Us
Filters
Showing results (251-260 of 436) with videos related to
Page
of 44
Sort By:
American Heart Journal
|
February 26, 2008
Noninvasive, medical management for non-ST-elevation acute coronary syndromes
Mark Y Chan, Richard C Becker, Robert A Harrington, et al.
American Heart Journal
|
January 31, 2006
Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction
Manesh R Patel, Trip J Meine, Lauren Lindblad, et al.
American Heart Journal
|
June 2, 2015
Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Hyun-Jae Kang, Robert M Clare, Runlin Gao, et al.
JAMA
|
May 23, 2013
Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial
Wei Jiang, Eric J Velazquez, Maragatha Kuchibhatla, et al.
Thrombosis and Haemostasis
|
February 15, 2018
Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study
Robert F Storey, Diego Ardissino, Luigi Vignali, et al.
Psychosomatic Medicine
|
October 29, 2013
Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease
Stephen H Boyle, Zainab Samad, Richard C Becker, et al.
Journal of Thrombosis and Thrombolysis
|
February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
Michael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
American Heart Journal
|
June 23, 2014
Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study
Axel Akerblom, Niclas Eriksson, Lars Wallentin, et al.
American Heart Journal
|
November 10, 2012
Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study
Axel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
Journal of Thrombosis and Thrombolysis
|
November 19, 2010
Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome
Richard C Becker, Kenneth W Mahaffey, Hongqiu Yang, et al.
Page
of 44
Search research articles
Search
Showing results (251-260 of 436) with videos related to
Sort By:
Page
of 44
American Heart Journal
|
February 26, 2008
Noninvasive, medical management for non-ST-elevation acute coronary syndromes
Mark Y Chan, Richard C Becker, Robert A Harrington, et al.
American Heart Journal
|
January 31, 2006
Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction
Manesh R Patel, Trip J Meine, Lauren Lindblad, et al.
American Heart Journal
|
June 2, 2015
Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial
Hyun-Jae Kang, Robert M Clare, Runlin Gao, et al.
JAMA
|
May 23, 2013
Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial
Wei Jiang, Eric J Velazquez, Maragatha Kuchibhatla, et al.
Thrombosis and Haemostasis
|
February 15, 2018
Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study
Robert F Storey, Diego Ardissino, Luigi Vignali, et al.
Psychosomatic Medicine
|
October 29, 2013
Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease
Stephen H Boyle, Zainab Samad, Richard C Becker, et al.
Journal of Thrombosis and Thrombolysis
|
February 11, 2012
Activated partial thromboplastin time measurement is not associated with clinical outcomes in patients with high-risk non-ST-segment elevation acute coronary syndromes treated with unfractionated heparin
Michael P Thomas, Kenneth W Mahaffey, Karen Chiswell, et al.
American Heart Journal
|
June 23, 2014
Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study
Axel Akerblom, Niclas Eriksson, Lars Wallentin, et al.
American Heart Journal
|
November 10, 2012
Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients -- results from the PLATelet inhibition and patient Outcomes (PLATO) study
Axel Akerblom, Lars Wallentin, Agneta Siegbahn, et al.
Journal of Thrombosis and Thrombolysis
|
November 19, 2010
Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome
Richard C Becker, Kenneth W Mahaffey, Hongqiu Yang, et al.
Page
of 44